Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Red Tree Venture Capital, founded in 2020, is based in Redwood City, California. The firm raised $272 million for its inaugural fund in 2022, focusing on early-stage investments in life sciences. Red Tree leverages relationships with leading West Coast academic institutions to source innovative companies.
Red Tree Venture Capital targets early-stage companies in biotech and healthcare, specifically those developing first-in-class and best-in-class therapeutics. The firm invests in significant unmet needs in oncology, neurology, and immunology, providing initial institutional capital to about half of its portfolio companies.
Red Tree has invested in notable companies such as Excellergy, Bicara Therapeutics, Rondo Therapeutics, Ceribell, and Engrail Therapeutics, all connected to premier West Coast institutions.
Submit your pitch through their website's contact form at [URL].
Yes, Red Tree often provides initial institutional capital, leading rounds for approximately half of the companies it funds.
Red Tree focuses primarily on early-stage funding but may consider follow-on investments depending on the progress and needs of the portfolio companies.
Red Tree's inaugural fund, closed in 2022, has a total size of $272 million.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.